Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
Aetion, Inc.
๐บ๐ธ
United States
Country
๐บ๐ธ
United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
CARE Initiative: Real-world Emulation of the PALOMA-2 Trial
Completed
Conditions
Metastatic Breast Cancer
Interventions
Drug: Palbociclib
Drug: Letrozole
Subscribe
First Posted Date
2024-09-23
Last Posted Date
2024-09-23
Lead Sponsor
Aetion, Inc.
Target Recruit Count
724
Registration Number
NCT06607601
Subscribe
CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]
Completed
Conditions
Metastatic Nonsmall Cell Lung Cancer
Interventions
Drug: Pemetrexed
Drug: Pembrolizumab
Drug: Carboplatin
Drug: Cisplatin
Subscribe
First Posted Date
2024-09-23
Last Posted Date
2024-09-23
Lead Sponsor
Aetion, Inc.
Target Recruit Count
851
Registration Number
NCT06607393
Subscribe
CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS4]
Completed
Conditions
Metastatic Non Small Cell Lung Cancer
Interventions
Drug: Pembrolizumab
Drug: Pemetrexed
Drug: Cisplatin
Drug: Carboplatin
Subscribe
First Posted Date
2024-09-05
Last Posted Date
2024-09-05
Lead Sponsor
Aetion, Inc.
Target Recruit Count
304
Registration Number
NCT06585189
Subscribe
Emulation of the KEYNOTE-189 Trial Using Electronic Health Records
Completed
Conditions
Non-small Cell Lung Cancer
Metastatic Lung Cancer
Interventions
Drug: Pembrolizumab + Pemetrexed-Platinum
Drug: Pemetrexed-Platinum
Subscribe
First Posted Date
2023-06-18
Last Posted Date
2023-09-13
Lead Sponsor
Aetion, Inc.
Target Recruit Count
1854
Registration Number
NCT05908799
Locations
๐บ๐ธ
Aetion, Boston, Massachusetts, United States
Subscribe
Methodologies for Observational Studies Comparing Inpatient COVID-19 Treatments
Active, not recruiting
Conditions
COVID-19
Interventions
Drug: Initiation of IL6Ri (tocilizumab or sarilumab) versus JAKi (baricitinib or tofacitinib) added to systemic corticosteroids of interest (CSI)
Subscribe
First Posted Date
2022-12-06
Last Posted Date
2023-09-08
Lead Sponsor
Aetion, Inc.
Target Recruit Count
3000
Registration Number
NCT05638932
Locations
๐บ๐ธ
Aetion, Inc., New York, New York, United States
Subscribe
Dexamethasone and COVID-19 Inpatient Mortality
Completed
Conditions
Coronavirus
Interventions
Drug: Dexamethasone Oral
Subscribe
First Posted Date
2021-06-15
Last Posted Date
2023-04-18
Lead Sponsor
Aetion, Inc.
Target Recruit Count
14105
Registration Number
NCT04926571
Locations
๐บ๐ธ
Aetion, Inc., New York, New York, United States
Subscribe
Prev
1
Next
ยฉ Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy